DiaSys Corp. Elects Stuart M. Robbins, Former Managing Director of Donaldson, Lufkin & Jenrette, to Expanded Board.Business Editors WATERBURY, Conn.--(BW HealthWire)--Oct. 29, 2001 DiaSys Corporation (AMEX AMEX See: American Stock Exchange :DYX DYX Dyslexia ) announced that Stuart M. Robbins, retired Managing Director of Donaldson, Lufkin & Jenrette, has been appointed to the Board of Directors, thereby expanding the DiaSys Board to six members. As Managing Director of Global Equities at Donaldson, Lufkin & Jenrette, Mr. Robbins managed one of the financial industry's most successful equities businesses. He was responsible for a worldwide division of over 1,500 people and revenues quintupled during his six-year tenure. Mr. Robbins' Wall Street career spans over 30 years during which he authored two widely-used retail industry financial manuals, was an Institutional Investor Institutional Investor A non-bank person or organization that trades securities in large enough share quantities or dollar amounts that they qualify for preferential treatment and lower commissions. All-Star analyst for eleven years and frequent featured speaker at many trade conventions and seminars. Todd M. DeMatteo, DiaSys President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. said, "We are delighted to welcome Stuart Robbins to the Board. His extensive financial experience and numerous achievements, clearly underscore how valuable he will be to DiaSys as we pursue our growth strategy." DiaSys Corporation designs, develops, manufactures and distributes medical laboratory instrumentation, consumables, reagents and test kits with applications in urinalysis, microbiology and cytology cytology (sītŏl`əjē), in biology, the study of the structure of all normal and abnormal components of cells and the changes, movements, and transformations of such components. . DiaSys is a registered trademark of DiaSys Corporation. The foregoing press release includes "forward looking statements" within the meaning of, and made pursuant to, the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such forward looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company or events, or timing of events, relating to the Company to materially differ from those expressed or implied by such forward looking statements. DiaSys refers interested parties to its most recent Annual Report on form 10-KSB and other SEC filings for a complete description of, and discussions about, the Company. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion